# n-3 Polyunsaturated Fatty Acids in Obesity

> **NCT00760760** · PHASE2 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 55 (actual)

## Conditions studied

- Adipose Tissue Inflammation
- Morbid Obesity

## Interventions

- **DRUG:** reesterified long-chain n-3 polyunsaturated fatty acids (EPA, DHA)
- **DRUG:** control

## Key facts

- **NCT ID:** NCT00760760
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2014-09
- **Final completion:** 2016-03
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2016-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760760, "n-3 Polyunsaturated Fatty Acids in Obesity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00760760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*